Skip to main content
. 2017 Feb 23;61(3):e02389-16. doi: 10.1128/AAC.02389-16

TABLE 2.

Clinical characteristics of skin infections

Demographic characteristic Total cohort (n = 293) Success (n = 224) Failure (n = 69) P value
Provider location, no. (%) 0.98
    Emergency room 127 (43.3) 97 (43.3) 30 (43.5)
    Primary care 166 (56.7) 127 (56.7) 39 (56.5)
Antibiotic prescribed, no. (%) 0.89
    Cephalexin 87 (29.7) 68 (30.4) 19 (27.5)
    Clindamycin 45 (15.4) 35 (15.6) 10 (14.5)
    TMP-SMX 96 (32.8) 71 (31.7) 25 (36.2)
    TMP plus cephalexin 8 (2.7) 7 (3.1) 1 (1.4)
    Other 57 (19.4) 43 (19.2) 14 (20.3)
Duration of treatment (days), mean ± SD 9.0 ± 1.92 8.94 ± 2.01 9.14 ± 1.59 0.43
Anatomic area, no. (%) 0.66
    Buttocks/groin 20 (6.8) 14 (6.2) 6 (8.7)
    Head/neck 50 (17.1) 38 (17) 12 (17.4)
    Lower extremity 172 (58.7) 129 (57.6) 43 (62.3)
    Trunk/abdomen 13 (4.4) 11 (4.9) 2 (2.9)
    Upper extremity 38 (13) 32 (14.3) 6 (8.7)
Incision and drainage, no. (%) 51 (17.4) 38 (20) 13 (18.8) 0.72
Type of infection, no. (%) 0.77
    Abscess 67 (22.9) 49 (21.9) 18 (26.1)
    Cellulitis 182 (62.1) 141 (62.9) 41 (59.4)
    Mixed 44 (15) 34 (15.2) 10 (14.5)
Culture result (n = 45), no. (%) 0.012
    Gram negative 1 (2.2) 1 (3.2) 0
    MRSA 14 (31.1) 5 (16.1) 9 (64.3)
    S. aureus 16 (35.6) 12 (38.7) 4 (28.6)
    Skin flora 11 (24.4) 11 (35.5) 0
    No growth 3 (6.7) 2 (6.4) 1 (7.1)
Hospitalization within 30 days, no. (%) 15 (5.1) 1 (0.5) 14 (20.3) <0.0001